Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients

Summary Background & aims High protein diets have been shown to improve hepatic steatosis in rodent models and in high-fat fed humans. We therefore evaluated the effects of a protein supplementation on intrahepatocellular lipids (IHCL), and fasting plasma triglycerides in obese non diabetic wome...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical nutrition (Edinburgh, Scotland) Scotland), 2011-08, Vol.30 (4), p.494-498
Hauptverfasser: Bortolotti, Murielle, Maiolo, Elena, Corazza, Mattia, Van Dijke, Eveline, Schneiter, Philippe, Boss, Andreas, Carrel, Guillaume, Giusti, Vittorio, Lê, Kim-Anne, Quo Chong, Daniel Guae, Buehler, Tania, Kreis, Roland, Boesch, Chris, Tappy, Luc
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 498
container_issue 4
container_start_page 494
container_title Clinical nutrition (Edinburgh, Scotland)
container_volume 30
creator Bortolotti, Murielle
Maiolo, Elena
Corazza, Mattia
Van Dijke, Eveline
Schneiter, Philippe
Boss, Andreas
Carrel, Guillaume
Giusti, Vittorio
Lê, Kim-Anne
Quo Chong, Daniel Guae
Buehler, Tania
Kreis, Roland
Boesch, Chris
Tappy, Luc
description Summary Background & aims High protein diets have been shown to improve hepatic steatosis in rodent models and in high-fat fed humans. We therefore evaluated the effects of a protein supplementation on intrahepatocellular lipids (IHCL), and fasting plasma triglycerides in obese non diabetic women. Methods Eleven obese women received a 60 g/day whey protein supplement (WPS) for 4-weeks, while otherwise nourished on a spontaneous diet, IHCL concentrations, visceral body fat, total liver volume (MR), fasting total-triglyceride and cholesterol concentrations, glucose tolerance (standard 75 g OGTT), insulin sensitivity (HOMA IS index), creatinine clearance, blood pressure and body composition (bio-impedance analysis) were assessed before and after 4-week WPS. Results IHCL were positively correlated with visceral fat and total liver volume at inclusion. WPS decreased significantly IHCL by 20.8 ± 7.7%, fasting total TG by 15 ± 6.9%, and total cholesterol by 7.3 ± 2.7%. WPS slightly increased fat free mass from 54.8 ± 2.2 kg to 56.7 ± 2.5 kg, p  = 0.005). Visceral fat, total liver volume, glucose tolerance, creatinine clearance and insulin sensitivity were not changed. Conclusions WPS improves hepatic steatosis and plasma lipid profiles in obese non diabetic patients, without adverse effects on glucose tolerance or creatinine clearance. Trial Number NCT00870077, ClinicalTrials.gov
doi_str_mv 10.1016/j.clnu.2011.01.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_880140046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0261561411000082</els_id><sourcerecordid>880140046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c506t-90cae9ab5d8cc6be611af3881c2ed2bad72a07f4a2337777fb047bcc1ca159ce3</originalsourceid><addsrcrecordid>eNp9kk2LFDEQhoMo7rj6BzxILuKpx6p0dzoNIsiyrsKCB_Uc0-kKmzH9YdKtzL83zYwreDAU5FDPW1W8VYw9R9gjoHx92NswrnsBiHvIAfIB22FdigJbVT5kOxASi1pidcGepHQAgLps1GN2IVAoJVHs2Ldr58guiU-OG_7rjo58jtNCfuRpnedAA42LWfw08hx-XKK5o9ksk6UQ1mAiD372fcopPnWUiDsaTCCeGZ-l6Sl75ExI9Oz8X7Kv76-_XH0obj_dfLx6d1vYGuRStGANtaare2Wt7EgiGlcqhVZQLzrTN8JA4yojyrLJz3VQNZ21aA3WraXykr061c3j_1gpLXrwaRvSjDStSSsFWAFUMpPiRNo4pRTJ6Tn6wcSjRtCbsfqgN2P1ZqyGHLCJXpzLr91A_b3kj5MZeHkGTLImuGhG69NfrsrNpWoz9-bEUTbjp6eok81GWep9zIvQ_eT_P8fbf-Q2-NHnjt_pSOkwrXHMNmvUSWjQn7cT2C4AMW8flCh_A1vYrYE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>880140046</pqid></control><display><type>article</type><title>Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Bortolotti, Murielle ; Maiolo, Elena ; Corazza, Mattia ; Van Dijke, Eveline ; Schneiter, Philippe ; Boss, Andreas ; Carrel, Guillaume ; Giusti, Vittorio ; Lê, Kim-Anne ; Quo Chong, Daniel Guae ; Buehler, Tania ; Kreis, Roland ; Boesch, Chris ; Tappy, Luc</creator><creatorcontrib>Bortolotti, Murielle ; Maiolo, Elena ; Corazza, Mattia ; Van Dijke, Eveline ; Schneiter, Philippe ; Boss, Andreas ; Carrel, Guillaume ; Giusti, Vittorio ; Lê, Kim-Anne ; Quo Chong, Daniel Guae ; Buehler, Tania ; Kreis, Roland ; Boesch, Chris ; Tappy, Luc</creatorcontrib><description>Summary Background &amp; aims High protein diets have been shown to improve hepatic steatosis in rodent models and in high-fat fed humans. We therefore evaluated the effects of a protein supplementation on intrahepatocellular lipids (IHCL), and fasting plasma triglycerides in obese non diabetic women. Methods Eleven obese women received a 60 g/day whey protein supplement (WPS) for 4-weeks, while otherwise nourished on a spontaneous diet, IHCL concentrations, visceral body fat, total liver volume (MR), fasting total-triglyceride and cholesterol concentrations, glucose tolerance (standard 75 g OGTT), insulin sensitivity (HOMA IS index), creatinine clearance, blood pressure and body composition (bio-impedance analysis) were assessed before and after 4-week WPS. Results IHCL were positively correlated with visceral fat and total liver volume at inclusion. WPS decreased significantly IHCL by 20.8 ± 7.7%, fasting total TG by 15 ± 6.9%, and total cholesterol by 7.3 ± 2.7%. WPS slightly increased fat free mass from 54.8 ± 2.2 kg to 56.7 ± 2.5 kg, p  = 0.005). Visceral fat, total liver volume, glucose tolerance, creatinine clearance and insulin sensitivity were not changed. Conclusions WPS improves hepatic steatosis and plasma lipid profiles in obese non diabetic patients, without adverse effects on glucose tolerance or creatinine clearance. Trial Number NCT00870077, ClinicalTrials.gov</description><identifier>ISSN: 0261-5614</identifier><identifier>EISSN: 1532-1983</identifier><identifier>DOI: 10.1016/j.clnu.2011.01.006</identifier><identifier>PMID: 21288612</identifier><identifier>CODEN: CLNUDP</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Adult ; Amino Acids - drug effects ; Biological and medical sciences ; Blood Glucose - analysis ; Blood Pressure - drug effects ; Body Composition - drug effects ; Cholesterol - blood ; Chromium ; Creatinine - metabolism ; Diet ; Dietary proteins ; Dietary Supplements ; Fasting ; Fatty Liver - drug therapy ; Feeding. Feeding behavior ; Female ; Fundamental and applied biological sciences. Psychology ; Gastroenterology and Hepatology ; Glucose tolerance ; Glucose Tolerance Test ; Humans ; Insulin - blood ; Insulin Resistance ; Intra-Abdominal Fat - metabolism ; Liver - metabolism ; Medical sciences ; Metabolic diseases ; Milk Proteins - pharmacology ; Nicotinic Acids ; Non-alcoholic fatty liver disease ; Obesity ; Obesity - drug therapy ; Organ Size ; Triglycerides - blood ; Vertebrates: anatomy and physiology, studies on body, several organs or systems ; Whey Proteins</subject><ispartof>Clinical nutrition (Edinburgh, Scotland), 2011-08, Vol.30 (4), p.494-498</ispartof><rights>Elsevier Ltd and European Society for Clinical Nutrition and Metabolism</rights><rights>2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c506t-90cae9ab5d8cc6be611af3881c2ed2bad72a07f4a2337777fb047bcc1ca159ce3</citedby><cites>FETCH-LOGICAL-c506t-90cae9ab5d8cc6be611af3881c2ed2bad72a07f4a2337777fb047bcc1ca159ce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0261561411000082$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24400689$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21288612$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bortolotti, Murielle</creatorcontrib><creatorcontrib>Maiolo, Elena</creatorcontrib><creatorcontrib>Corazza, Mattia</creatorcontrib><creatorcontrib>Van Dijke, Eveline</creatorcontrib><creatorcontrib>Schneiter, Philippe</creatorcontrib><creatorcontrib>Boss, Andreas</creatorcontrib><creatorcontrib>Carrel, Guillaume</creatorcontrib><creatorcontrib>Giusti, Vittorio</creatorcontrib><creatorcontrib>Lê, Kim-Anne</creatorcontrib><creatorcontrib>Quo Chong, Daniel Guae</creatorcontrib><creatorcontrib>Buehler, Tania</creatorcontrib><creatorcontrib>Kreis, Roland</creatorcontrib><creatorcontrib>Boesch, Chris</creatorcontrib><creatorcontrib>Tappy, Luc</creatorcontrib><title>Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients</title><title>Clinical nutrition (Edinburgh, Scotland)</title><addtitle>Clin Nutr</addtitle><description>Summary Background &amp; aims High protein diets have been shown to improve hepatic steatosis in rodent models and in high-fat fed humans. We therefore evaluated the effects of a protein supplementation on intrahepatocellular lipids (IHCL), and fasting plasma triglycerides in obese non diabetic women. Methods Eleven obese women received a 60 g/day whey protein supplement (WPS) for 4-weeks, while otherwise nourished on a spontaneous diet, IHCL concentrations, visceral body fat, total liver volume (MR), fasting total-triglyceride and cholesterol concentrations, glucose tolerance (standard 75 g OGTT), insulin sensitivity (HOMA IS index), creatinine clearance, blood pressure and body composition (bio-impedance analysis) were assessed before and after 4-week WPS. Results IHCL were positively correlated with visceral fat and total liver volume at inclusion. WPS decreased significantly IHCL by 20.8 ± 7.7%, fasting total TG by 15 ± 6.9%, and total cholesterol by 7.3 ± 2.7%. WPS slightly increased fat free mass from 54.8 ± 2.2 kg to 56.7 ± 2.5 kg, p  = 0.005). Visceral fat, total liver volume, glucose tolerance, creatinine clearance and insulin sensitivity were not changed. Conclusions WPS improves hepatic steatosis and plasma lipid profiles in obese non diabetic patients, without adverse effects on glucose tolerance or creatinine clearance. Trial Number NCT00870077, ClinicalTrials.gov</description><subject>Adult</subject><subject>Amino Acids - drug effects</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - analysis</subject><subject>Blood Pressure - drug effects</subject><subject>Body Composition - drug effects</subject><subject>Cholesterol - blood</subject><subject>Chromium</subject><subject>Creatinine - metabolism</subject><subject>Diet</subject><subject>Dietary proteins</subject><subject>Dietary Supplements</subject><subject>Fasting</subject><subject>Fatty Liver - drug therapy</subject><subject>Feeding. Feeding behavior</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gastroenterology and Hepatology</subject><subject>Glucose tolerance</subject><subject>Glucose Tolerance Test</subject><subject>Humans</subject><subject>Insulin - blood</subject><subject>Insulin Resistance</subject><subject>Intra-Abdominal Fat - metabolism</subject><subject>Liver - metabolism</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Milk Proteins - pharmacology</subject><subject>Nicotinic Acids</subject><subject>Non-alcoholic fatty liver disease</subject><subject>Obesity</subject><subject>Obesity - drug therapy</subject><subject>Organ Size</subject><subject>Triglycerides - blood</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><subject>Whey Proteins</subject><issn>0261-5614</issn><issn>1532-1983</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kk2LFDEQhoMo7rj6BzxILuKpx6p0dzoNIsiyrsKCB_Uc0-kKmzH9YdKtzL83zYwreDAU5FDPW1W8VYw9R9gjoHx92NswrnsBiHvIAfIB22FdigJbVT5kOxASi1pidcGepHQAgLps1GN2IVAoJVHs2Ldr58guiU-OG_7rjo58jtNCfuRpnedAA42LWfw08hx-XKK5o9ksk6UQ1mAiD372fcopPnWUiDsaTCCeGZ-l6Sl75ExI9Oz8X7Kv76-_XH0obj_dfLx6d1vYGuRStGANtaare2Wt7EgiGlcqhVZQLzrTN8JA4yojyrLJz3VQNZ21aA3WraXykr061c3j_1gpLXrwaRvSjDStSSsFWAFUMpPiRNo4pRTJ6Tn6wcSjRtCbsfqgN2P1ZqyGHLCJXpzLr91A_b3kj5MZeHkGTLImuGhG69NfrsrNpWoz9-bEUTbjp6eok81GWep9zIvQ_eT_P8fbf-Q2-NHnjt_pSOkwrXHMNmvUSWjQn7cT2C4AMW8flCh_A1vYrYE</recordid><startdate>20110801</startdate><enddate>20110801</enddate><creator>Bortolotti, Murielle</creator><creator>Maiolo, Elena</creator><creator>Corazza, Mattia</creator><creator>Van Dijke, Eveline</creator><creator>Schneiter, Philippe</creator><creator>Boss, Andreas</creator><creator>Carrel, Guillaume</creator><creator>Giusti, Vittorio</creator><creator>Lê, Kim-Anne</creator><creator>Quo Chong, Daniel Guae</creator><creator>Buehler, Tania</creator><creator>Kreis, Roland</creator><creator>Boesch, Chris</creator><creator>Tappy, Luc</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110801</creationdate><title>Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients</title><author>Bortolotti, Murielle ; Maiolo, Elena ; Corazza, Mattia ; Van Dijke, Eveline ; Schneiter, Philippe ; Boss, Andreas ; Carrel, Guillaume ; Giusti, Vittorio ; Lê, Kim-Anne ; Quo Chong, Daniel Guae ; Buehler, Tania ; Kreis, Roland ; Boesch, Chris ; Tappy, Luc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c506t-90cae9ab5d8cc6be611af3881c2ed2bad72a07f4a2337777fb047bcc1ca159ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Amino Acids - drug effects</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - analysis</topic><topic>Blood Pressure - drug effects</topic><topic>Body Composition - drug effects</topic><topic>Cholesterol - blood</topic><topic>Chromium</topic><topic>Creatinine - metabolism</topic><topic>Diet</topic><topic>Dietary proteins</topic><topic>Dietary Supplements</topic><topic>Fasting</topic><topic>Fatty Liver - drug therapy</topic><topic>Feeding. Feeding behavior</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gastroenterology and Hepatology</topic><topic>Glucose tolerance</topic><topic>Glucose Tolerance Test</topic><topic>Humans</topic><topic>Insulin - blood</topic><topic>Insulin Resistance</topic><topic>Intra-Abdominal Fat - metabolism</topic><topic>Liver - metabolism</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Milk Proteins - pharmacology</topic><topic>Nicotinic Acids</topic><topic>Non-alcoholic fatty liver disease</topic><topic>Obesity</topic><topic>Obesity - drug therapy</topic><topic>Organ Size</topic><topic>Triglycerides - blood</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><topic>Whey Proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bortolotti, Murielle</creatorcontrib><creatorcontrib>Maiolo, Elena</creatorcontrib><creatorcontrib>Corazza, Mattia</creatorcontrib><creatorcontrib>Van Dijke, Eveline</creatorcontrib><creatorcontrib>Schneiter, Philippe</creatorcontrib><creatorcontrib>Boss, Andreas</creatorcontrib><creatorcontrib>Carrel, Guillaume</creatorcontrib><creatorcontrib>Giusti, Vittorio</creatorcontrib><creatorcontrib>Lê, Kim-Anne</creatorcontrib><creatorcontrib>Quo Chong, Daniel Guae</creatorcontrib><creatorcontrib>Buehler, Tania</creatorcontrib><creatorcontrib>Kreis, Roland</creatorcontrib><creatorcontrib>Boesch, Chris</creatorcontrib><creatorcontrib>Tappy, Luc</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nutrition (Edinburgh, Scotland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bortolotti, Murielle</au><au>Maiolo, Elena</au><au>Corazza, Mattia</au><au>Van Dijke, Eveline</au><au>Schneiter, Philippe</au><au>Boss, Andreas</au><au>Carrel, Guillaume</au><au>Giusti, Vittorio</au><au>Lê, Kim-Anne</au><au>Quo Chong, Daniel Guae</au><au>Buehler, Tania</au><au>Kreis, Roland</au><au>Boesch, Chris</au><au>Tappy, Luc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients</atitle><jtitle>Clinical nutrition (Edinburgh, Scotland)</jtitle><addtitle>Clin Nutr</addtitle><date>2011-08-01</date><risdate>2011</risdate><volume>30</volume><issue>4</issue><spage>494</spage><epage>498</epage><pages>494-498</pages><issn>0261-5614</issn><eissn>1532-1983</eissn><coden>CLNUDP</coden><abstract>Summary Background &amp; aims High protein diets have been shown to improve hepatic steatosis in rodent models and in high-fat fed humans. We therefore evaluated the effects of a protein supplementation on intrahepatocellular lipids (IHCL), and fasting plasma triglycerides in obese non diabetic women. Methods Eleven obese women received a 60 g/day whey protein supplement (WPS) for 4-weeks, while otherwise nourished on a spontaneous diet, IHCL concentrations, visceral body fat, total liver volume (MR), fasting total-triglyceride and cholesterol concentrations, glucose tolerance (standard 75 g OGTT), insulin sensitivity (HOMA IS index), creatinine clearance, blood pressure and body composition (bio-impedance analysis) were assessed before and after 4-week WPS. Results IHCL were positively correlated with visceral fat and total liver volume at inclusion. WPS decreased significantly IHCL by 20.8 ± 7.7%, fasting total TG by 15 ± 6.9%, and total cholesterol by 7.3 ± 2.7%. WPS slightly increased fat free mass from 54.8 ± 2.2 kg to 56.7 ± 2.5 kg, p  = 0.005). Visceral fat, total liver volume, glucose tolerance, creatinine clearance and insulin sensitivity were not changed. Conclusions WPS improves hepatic steatosis and plasma lipid profiles in obese non diabetic patients, without adverse effects on glucose tolerance or creatinine clearance. Trial Number NCT00870077, ClinicalTrials.gov</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>21288612</pmid><doi>10.1016/j.clnu.2011.01.006</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0261-5614
ispartof Clinical nutrition (Edinburgh, Scotland), 2011-08, Vol.30 (4), p.494-498
issn 0261-5614
1532-1983
language eng
recordid cdi_proquest_miscellaneous_880140046
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Amino Acids - drug effects
Biological and medical sciences
Blood Glucose - analysis
Blood Pressure - drug effects
Body Composition - drug effects
Cholesterol - blood
Chromium
Creatinine - metabolism
Diet
Dietary proteins
Dietary Supplements
Fasting
Fatty Liver - drug therapy
Feeding. Feeding behavior
Female
Fundamental and applied biological sciences. Psychology
Gastroenterology and Hepatology
Glucose tolerance
Glucose Tolerance Test
Humans
Insulin - blood
Insulin Resistance
Intra-Abdominal Fat - metabolism
Liver - metabolism
Medical sciences
Metabolic diseases
Milk Proteins - pharmacology
Nicotinic Acids
Non-alcoholic fatty liver disease
Obesity
Obesity - drug therapy
Organ Size
Triglycerides - blood
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Whey Proteins
title Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T13%3A03%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20a%20whey%20protein%20supplementation%20on%20intrahepatocellular%20lipids%20in%20obese%20female%20patients&rft.jtitle=Clinical%20nutrition%20(Edinburgh,%20Scotland)&rft.au=Bortolotti,%20Murielle&rft.date=2011-08-01&rft.volume=30&rft.issue=4&rft.spage=494&rft.epage=498&rft.pages=494-498&rft.issn=0261-5614&rft.eissn=1532-1983&rft.coden=CLNUDP&rft_id=info:doi/10.1016/j.clnu.2011.01.006&rft_dat=%3Cproquest_cross%3E880140046%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=880140046&rft_id=info:pmid/21288612&rft_els_id=1_s2_0_S0261561411000082&rfr_iscdi=true